Position in ARGX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$27,825,444
-$17,913,825 QoQ
Shares Held
38,104
-29.9% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 94.95853453705647.ToString("F0")%
Shared 0.ToString("F0")%
None 5.041465462943523.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,850,561 across 389 Biotechnology names. ARGX ranks #8 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
This page
|
38,104 | $27,825,444 |
All Filings in ARGX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,825,444 | 38,104 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $45,739,269 | 54,390 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $41,062,914 | 55,674 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $30,527,113 | 55,381 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $39,810,613 | 67,263 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $32,417,265 | 52,711 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $24,698,248 | 45,562 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $19,873,007 | 46,212 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $18,749,339 | 47,621 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $16,105,502 | 42,335 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $27,577,983 | 56,095 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $10,612,347 | 27,230 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $10,005,261 | 26,854 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $9,885,568 | 26,095 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,286,979 | 26,305 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,648,393 | 36,023 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $11,046,884 | 35,035 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,490,640 | 29,957 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,229,422 | 30,561 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,108,562 | 23,611 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $7,467,749 | 27,117 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $8,072,181 | 27,448 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $7,184,908 | 27,369 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $5,410,699 | 24,023 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,016,616 | 22,900 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||